215 related articles for article (PubMed ID: 15701886)
1. Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
Colditz GA
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):909s-17s. PubMed ID: 15701886
[TBL] [Abstract][Full Text] [Related]
2. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
5. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
6. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
9. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada.
Kirsh V; Kreiger N
Cancer Causes Control; 2002 Aug; 13(6):583-90. PubMed ID: 12195648
[TBL] [Abstract][Full Text] [Related]
11. Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.
Colditz GA
Breast Cancer Res; 2007; 9(4):108. PubMed ID: 17666116
[TBL] [Abstract][Full Text] [Related]
12. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
Kerlikowske K; Cook AJ; Buist DS; Cummings SR; Vachon C; Vacek P; Miglioretti DL
J Clin Oncol; 2010 Aug; 28(24):3830-7. PubMed ID: 20644098
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
15. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
16. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Kuller LH
J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
[No Abstract] [Full Text] [Related]
17. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
[TBL] [Abstract][Full Text] [Related]
18. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Archer DF; Bush T; Nachtigall LE
J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
[No Abstract] [Full Text] [Related]
19. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
Schairer C; Brinton LA
J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
[No Abstract] [Full Text] [Related]
20. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).
Schairer C; Byrne C; Keyl PM; Brinton LA; Sturgeon SR; Hoover RN
Cancer Causes Control; 1994 Nov; 5(6):491-500. PubMed ID: 7827235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
